For decades, the treatment of clinical mastitis was focused on resolving the clinical signs, so the cow can continue to be milked. With a growing understanding of the biology and epidemiology of mastitis – as well as tightening market requirements for milk quality – bacteriological cure and a low cell count have become the main objectives of mastitis treatment.